Santhera Pharmaceuticals Holding AG (SPHDF)
USD 9.42
(0.0%)
USD 9.42
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 122.95 Million | 8.08 Million | -1.74 Million | 16.97 Million | 77.83 Million | 32.11 Million |
| Cost of Revenue | 3.84 Million | 4.54 Million | 4.87 Million | 16.43 Million | 7.41 Million | 5.48 Million |
| Gross Profit | 119.1 Million | 3.53 Million | -6.62 Million | 541.88 Thousand | 70.42 Million | 26.63 Million |
| Operating Expenses | 37.25 Million | 53.13 Million | 55.99 Million | 61.13 Million | 77.23 Million | 78.9 Million |
| Selling, General and Administrative Expenses | 30.96 Million | 20.11 Million | 23.42 Million | 22.41 Million | 34.64 Million | 40.11 Million |
| Research and Development Expenses | 18.67 Million | 33.02 Million | 32.57 Million | 38.72 Million | 42.59 Million | 38.79 Million |
| Other Expenses | -12.38 Million | - | - | - | - | - |
| Cost and Expenses | 41.1 Million | 57.68 Million | 60.87 Million | 77.57 Million | 84.65 Million | 84.38 Million |
| Operating Income | 81.85 Million | -49.6 Million | -62.62 Million | -60.59 Million | -6.81 Million | -52.27 Million |
| Interest Expense | 21.31 Million | 21.83 Million | 16.42 Million | 6.89 Million | 6.08 Million | 4.56 Million |
| Income Tax Expense | 45.18 Thousand | 497.44 Thousand | 886.74 Thousand | 229.65 Thousand | 597.92 Thousand | 326.63 Thousand |
| Earnings before Tax | 54.82 Million | -76.36 Million | -59.97 Million | -76.31 Million | -18.99 Million | -54.63 Million |
| Net Income | 65.13 Million | -76.86 Million | -60.86 Million | -76.54 Million | -19.59 Million | -54.96 Million |
| Earnings Per Share Basic | 5.95 | -12.62 | -17.81 | -57.48 | -17.83 | -79.76 |
| Earnings Per Share Diluted | 5.96 | -12.62 | -17.81 | -57.48 | -17.83 | -79.76 |
| Weighted Average Shares Outstanding | 10.93 Million | 6.09 Million | 3.41 Million | 1.33 Million | 1.09 Million | 689.16 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 10.92 Million | 6.09 Million | 3.41 Million | 1.33 Million | 1.09 Million | 689.16 Thousand |
| Gross Margin | 0.97 | 0.44 | 3.79 | 0.03 | 0.90 | 0.83 |
| EBIT Margin | 0.76 | -5.65 | 33.49 | -3.09 | -0.02 | -1.51 |
| Profit Margin | 0.53 | -9.51 | 34.81 | -4.51 | -0.25 | -1.71 |
| EBITDA | 94.03 Million | -45.65 Million | -37.89 Million | -52.52 Million | -7.78 Million | -46.27 Million |
| Earnings Before Tax Margin | 0.67 | -6.14 | 35.82 | -3.57 | -0.09 | -1.63 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 7.85 Million | 7.82 Million | 118.1 Million | 122.78 Million | 54.33 Million | 4.39 Million |
| Cost of Revenue | 2.9 Million | 2.89 Million | 1.94 Million | 4.59 Million | 713.9 Thousand | 2.49 Million |
| Gross Profit | 4.95 Million | 4.93 Million | 116.16 Million | 118.18 Million | 53.62 Million | 1.9 Million |
| Operating Expenses | 14.82 Million | 14.76 Million | 32.01 Million | 58.2 Million | 3.89 Million | 24.62 Million |
| Selling, General and Administrative Expenses | 7.19 Million | 7.16 Million | 21.41 Million | - | 10.02 Million | 13.73 Million |
| Research and Development Expenses | 7.66 Million | 7.63 Million | 10.6 Million | - | 4.87 Million | 10.88 Million |
| Other Expenses | -31.16 Thousand | -31.04 Thousand | - | - | - | - |
| Cost and Expenses | 17.73 Million | 17.66 Million | 33.95 Million | 62.8 Million | 4.61 Million | 27.11 Million |
| Operating Income | -9.87 Million | -9.83 Million | 84.14 Million | 59.98 Million | 39.03 Million | -22.71 Million |
| Interest Expense | 4.48 Million | - | 30.11 Million | 39.64 Million | - | 8.95 Million |
| Income Tax Expense | 96.84 Thousand | 96.46 Thousand | 146.09 Thousand | 46.32 Thousand | 66.63 Thousand | -93.8 Thousand |
| Earnings before Tax | -8.39 Million | -8.36 Million | 92.92 Million | 65.11 Million | 42.73 Million | -26.15 Million |
| Net Income | -8.49 Million | -8.46 Million | 92.78 Million | 54.78 Million | 42.66 Million | -26.05 Million |
| Earnings Per Share Basic | -0.75 | -0.75 | 8.31 | - | 3.99 | -2.34 |
| Earnings Per Share Diluted | -0.75 | -0.75 | 8.31 | - | 3.99 | -2.34 |
| Weighted Average Shares Outstanding | 11.33 Million | 11.33 Million | 11.15 Million | 11.15 Million | 10.69 Million | 11.15 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.33 Million | 11.33 Million | 11.15 Million | 11.15 Million | 10.68 Million | 11.15 Million |
| Gross Margin | 0.63 | 0.63 | 0.98 | 0.96 | 0.99 | 0.43 |
| EBIT Margin | -1.06 | -1.06 | 0.72 | - | 0.73 | -4.70 |
| Profit Margin | -1.08 | -1.08 | 0.79 | 0.45 | 0.79 | -5.92 |
| EBITDA | -8.33 Million | -8.29 Million | 85.58 Million | - | 39.45 Million | -20.68 Million |
| Earnings Before Tax Margin | -1.26 | -1.26 | 0.71 | 0.49 | 0.72 | -5.17 |
RKIGF
VRG
ESSARSHPNG
WANSF
RHCGF
HS2